NAC Disciplinary Hearings for Jon Jones, Nate Diaz, Brock Lesnar Postponed
Monday’s Nevada Athletic Commission meeting just lost three-quarters of its star power.
Advertisement
Jones, the interim 205-pound champ, was granted a continuance after failing an out-of-competition drug test ahead of his light heavyweight title unification bout against Daniel Cormier at UFC 200. The Jackson-Wink MMA standout tested positive for two estrogen blocking substances, hydroxyclomiphene and letrozole metabolite, in a drug screening administered by USADA on June 16. Jones faces up to a two-year suspension for the potential anti-doping violation but has expressed optimism that his return could be sooner than anticipated.
Diaz, meanwhile, likely faces a fine for his part in a water-bottle throwing melee between his camp and Conor McGregor at a press conference prior to UFC 202. McGregor’s hearing will take place on Monday as planned.
Lesnar failed both in- and out-of-competition drug tests for the estrogen blocker clomiphene in relation to UFC 200. Lesnar was able to face and defeat Mark Hunt via unanimous decision on the card because the results from the WADA-accredited UCLA Olympic Analytical Lab were received on July 14, five days after the event. Like Jones, Lesnar could be suspended for up to two years.
Related Articles